Steven Smith
Operationeel Directeur bij AshHill Investments LLC
Actieve functies van Steven Smith
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AshHill Investments LLC
 AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Operationeel Directeur | - | - |
| Cincinnati | Private Equity Investor | - | - |
Loopbaan van Steven Smith
Eerdere bekende functies van Steven Smith
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Directeur/Bestuurslid | - | - |
Opleiding van Steven Smith
| University of Cincinnati (Ohio) | Undergraduate Degree |
| University of Dayton School of Law | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Ierland | 2 |
Operationeel
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Finance |
| Cincinnati | Finance |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- Steven Smith
- Ervaring
